Jean‐Luc Coll

12.8k total citations · 1 hit paper
252 papers, 10.0k citations indexed

About

Jean‐Luc Coll is a scholar working on Molecular Biology, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jean‐Luc Coll has authored 252 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 76 papers in Biomedical Engineering and 46 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jean‐Luc Coll's work include Nanoplatforms for cancer theranostics (52 papers), RNA Interference and Gene Delivery (38 papers) and Nanoparticle-Based Drug Delivery (32 papers). Jean‐Luc Coll is often cited by papers focused on Nanoplatforms for cancer theranostics (52 papers), RNA Interference and Gene Delivery (38 papers) and Nanoparticle-Based Drug Delivery (32 papers). Jean‐Luc Coll collaborates with scholars based in France, United States and Germany. Jean‐Luc Coll's co-authors include Lucie Sancey, Véronique Josserand, Amandine Hurbin, Sandrine Dufort, Benoît Busser, Élisabeth Brambilla, Didier Boturyn, Marie Favrot, Marie‐Christine Favrot and Pascal Dumy and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Jean‐Luc Coll

244 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hybrid Gadolinium Oxide Nanoparticles: Multimodal Contrast Agents for in Vivo Imaging

2007 635 citations Véronique Josserand, Jean‐Luc Coll et al. profile →

Peers

Countries citing papers authored by Jean‐Luc Coll

Since Specialization

Citations

This map shows the geographic impact of Jean‐Luc Coll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Luc Coll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Luc Coll more than expected).

Fields of papers citing papers by Jean‐Luc Coll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Luc Coll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Luc Coll. The network helps show where Jean‐Luc Coll may publish in the future.

Co-authorship network of co-authors of Jean‐Luc Coll

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Luc Coll. A scholar is included among the top collaborators of Jean‐Luc Coll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Luc Coll. Jean‐Luc Coll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combined physical and biological contributions to radiotherapy enhancement by Lu-based nanoscintillators in pancreatic cancer models 2025 ·Nanotheranostics ·(unknown), (unknown), (unknown), (unknown), (unknown), Malika Kadri, (unknown), Christine Moriscot, Benoît Gallet, Benoît Chovelon, Jean‐Luc Coll, Jean‐Luc Ravanat, E. Mihóková, Václav Čuba, Hélène Elleaume, Anne‐Laure Bulin	1
2	Multifunctional micro/nano-textured titanium with bactericidal, osteogenic, angiogenic and anti-inflammatory properties: Insights from in vitro and in vivo studies 2025 ·Materials Today Bio ·(unknown), (unknown), (unknown), (unknown), (unknown), Julien Vollaire, Véronique Josserand, Denver P. Linklater, Phuc H. Le, Jean‐Luc Coll, G. Bettega, Elena P. Ivanova, Véronique Martel‐Frachet	1
3	Novel strategies for enhanced fluorescence visualization of glioblastoma tumors based on HPMA copolymers conjugated with tumor targeting and/or cell‐penetrating peptides 2024 ·SHILAP Revista de lepidopterología ·(unknown), Robert Pola, Marcela Filipová, Maxime Henry, Jean‐Luc Coll, Tomáš Etrych	5
4	Quantifying Titanium Exposure in Lung Tissues: A Novel Laser‐Induced Breakdown Spectroscopy Elemental Imaging‐Based Analytical Framework for Biomedical Applications 2024 ·SHILAP Revista de lepidopterología ·(unknown), Lucie Sancey, (unknown), Laurent Gaté, Frédéric Cosnier, Carole Seidel, Sarah Valentino, Frédéric Pelascini, Jean‐Luc Coll, Michel Péoc’h, (unknown), (unknown), Vincent Bonneterre, Christophe Dujardin, Benoît Busser, Vincent Motto‐Ros	5
5	NIR-II Aza-BODIPY Dyes Bioconjugated to Monoclonal Antibody Trastuzumab for Selective Imaging of HER2-Positive Ovarian Cancer 2023 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Benoît Busser, K. David Wegner, Franck Denat, Xavier Le Guével, Jean‐Luc Coll, Catherine Paul, Ewen Bodio, Christine Goze, Lucie Sancey	18
6	Stimuli‐Responsive Polymer Nanoprobes Intended for Fluorescence‐Guided Surgery of Malignant Head‐and‐Neck Tumors and Metastases 2023 ·Advanced Healthcare Materials ·Robert Pola, (unknown), Michal Pechar, (unknown), (unknown), Jan Pankrác, Maxime Henry, (unknown), J Bouček, Luděk Šefc, Jean‐Luc Coll, Tomáš Etrych	3
7	Lipoprotein interactions with water-soluble NIR-II emitting aza-BODIPYs boost the fluorescence signal and favor selective tumor targeting 2022 ·Biomaterials Science ·(unknown), (unknown), Benoît Busser, (unknown), Fabien Dalonneau, Catherine Paul, Xavier Le Guével, Véronique Josserand, Jean‐Luc Coll, Franck Denat, Ewen Bodio, Christine Goze, Thomas Gautier, Lucie Sancey	12
8	Optimizing the Pharmacological and Optical Dosimetry for Photodynamic Therapy with Methylene Blue and Nanoliposomal Benzoporphyrin on Pancreatic Cancer Spheroids 2022 ·SPIRE - Sciences Po Institutional REpository ·(unknown), (unknown), (unknown), Jean‐Luc Coll, Mans Broekgaarden	7
9	Water-Soluble Aza-BODIPYs: Biocompatible Organic Dyes for High Contrast In Vivo NIR-II Imaging 2020 ·Bioconjugate Chemistry ·(unknown), (unknown), (unknown), Benoît Busser, Xavier Le Guével, K. David Wegner, Ute Resch‐Genger, Yoann Rousselin, Jean‐Luc Coll, Franck Denat, Ewen Bodio, Christine Goze, Lucie Sancey	72
10	Aza-BODIPY: A New Vector for Enhanced Theranostic Boron Neutron Capture Therapy Applications 2020 ·Cells ·(unknown), (unknown), Benoît Busser, (unknown), Mans Broekgaarden, Vincent Motto‐Ros, K. David Wegner, Ute Resch‐Genger, U. Köster, Franck Denat, Jean‐Luc Coll, Ewen Bodio, Christine Goze, Lucie Sancey	36
11	Polyheteroaryl Oxazole/Pyridine-Based Compounds Selected in Vitro as G-Quadruplex Ligands Inhibit Rock Kinase and Exhibit Antiproliferative Activity 2018 ·Journal of Medicinal Chemistry ·Daniela Verga, Chi-Hung Nguyen, (unknown), Jean‐Luc Coll, Marie‐Paule Teulade‐Fichou, Annie Molla	15
12	Systemic Delivery of Tumor-Targeted Bax-Derived Membrane-Active Peptides for the Treatment of Melanoma Tumors in a Humanized SCID Mouse Model 2017 ·Molecular Therapy ·(unknown), (unknown), (unknown), Caroline Aspord, (unknown), Corinne Leloup, Jérôme Kucharczak, Joël Plumas, Maxime Henry, Amandine Hurbin, Pascal Verdié, Jean Martínez, Gilles Subra, Pascal Dumy, Didier Boturyn, Abdel Aouacheria, Jean‐Luc Coll	19
13	Enhancing Lung Tumor Visibility Using In-Vivo Analyzer-Based X-Ray Phase Contrast Imaging In Mouse : A Feasibility Study 2017 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Ludovic Broche, Jean‐Luc Coll, Anders Larsson, Sam Bayat, Alberto Bravin	1
14	LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers 2016 ·Cancer Research ·Chloé Prunier, Véronique Josserand, Julien Vollaire, Evelyne Beerling, Christos J. Petropoulos, Olivier Destaing, Christopher Montemagno, Amandine Hurbin, Renaud Prudent, Leanne de Koning, Reuben Kapur, Pascale A. Cohen, Corinne Albigès‐Rizo, Jean‐Luc Coll, Jacco van Rheenen, Marc Billaud, Laurence Lafanéchère	27
15	Toward noninvasive assessment of flap viability with time-resolved diffuse optical tomography: a preclinical test on rats 2016 ·Journal of Biomedical Optics ·Laura Di Sieno, G. Bettega, (unknown), Michel Berger, Cynthia Hamou, Alberto Dalla Mora, (unknown), (unknown), Davide Contini, Lionel Hervé, Jean‐Luc Coll, Jean‐Marc Dinten, Antonio Pifferi, (unknown)	13
16	ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion 2012 ·Cancer Research ·Julie A. Vendrell, Aurélie Thollet, Nhan Trung Nguyen, Sandra E. Ghayad, Stéphanie Vinot, Ivan Bièche, (unknown), Véronique Josserand, Jean‐Luc Coll, Pierre Roux, Laura Corbo, Isabelle Treilleux, Ruth Rimokh, Pascale A. Cohen	95
17	101: Identification of differential pathways in mucinous and non-mucinous subtypes of lung adenocarcinoma suggested new therapeutic strategies 2010 ·Bulletin du Cancer ·Amandine Hurbin, Benoît Busser, Élisabeth Brambilla, Denis Moro‐Sibilot, Martine Antoine, Virginie Poulot, Jean‐Luc Coll, Marie Wislez, J. Cadranel	2
18	Small-Molecule Drugs Mimicking DNA Damage: A New Strategy for Sensitizing Tumors to Radiotherapy 2009 ·Clinical Cancer Research ·Maria Quanz, Nathalie Berthault, (unknown), Maryline Roy, Aurélie Herbette, (unknown), Christophe Alberti, Véronique Josserand, Jean‐Luc Coll, Xavier Sastre‐Garau, Jean‐Marc Cosset, Lionel Larue, Jian‐Sheng Sun, Marie Dutreix	76
19	Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody‐derivatized polyethylenimines (PEI) 1999 ·The Journal of Gene Medicine ·Patrick Erbacher, Thierry Bettinger, Pascale Belguise-Valladier, Shaomin Zou, Jean‐Luc Coll, Jean‐Paul Behr, Jean-Serge Rémy	6
20	Los Mayas hoy 1999 ·PubMed ·(unknown), Jean‐Luc Coll, Isabelle Puisieux	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact